These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7981244)

  • 1. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
    Wu-Wong JR; Chiou WJ; Magnuson SR; Opgenorth TJ
    Biochim Biophys Acta; 1994 Nov; 1224(2):288-94. PubMed ID: 7981244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.
    Wu-Wong JR; Chiou WJ; Naugles KE; Opgenorth TJ
    Life Sci; 1994; 54(22):1727-34. PubMed ID: 8177014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
    Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S380-4. PubMed ID: 8587421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.
    Chiou WJ; Magnuson SR; Dixon D; Sundy S; Opgenorth TJ; Wu-Wong JR
    Endothelium; 1997; 5(3):179-89. PubMed ID: 9272381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human astrocytoma U138MG cells express predominantly type-A endothelin receptor.
    Wu-Wong JR; Chiou W; Magnuson SR; Bianchi BR; Lin CW
    Biochim Biophys Acta; 1996 May; 1311(3):155-63. PubMed ID: 8664342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization.
    Wu-Wong JR; Chiou WJ; Magnuson SR; Opgenorth TJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):499-507. PubMed ID: 7616437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.
    Harada N; Himeno A; Shigematsu K; Sumikawa K; Niwa M
    Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity interaction of endothelin-3 with recombinant ETA receptors.
    Desmarets J; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(2):357-60. PubMed ID: 10079188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.
    Nambi P; Pullen M; Spielman W
    J Pharmacol Exp Ther; 1994 Jan; 268(1):202-7. PubMed ID: 8301559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different localization of ETA and ETB receptors in the hyperplastic vascular wall.
    Azuma H; Hamasaki H; Sato J; Isotani E; Obayashi S; Matsubara O
    J Cardiovasc Pharmacol; 1995 May; 25(5):802-9. PubMed ID: 7630158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of follicle-stimulating hormone on endothelin receptors in cultured rat ovarian granulosa cells.
    Usuki S; Kobayashi S; Sugimoto M; Kotani E; Otani S; Kubo T; Ishii T; Murakami K; Miyazaki H
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S225-9. PubMed ID: 9595444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes.
    McDonald DM; Bailie JR; Archer DB; Chakravarthy U
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1088-94. PubMed ID: 7730018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ligand, [125I]BQ-3020, reveals the localization of endothelin ETB receptors.
    Kobayashi M; Ihara M; Sato N; Saeki T; Ozaki S; Ikemoto F; Yano M
    Eur J Pharmacol; 1993 Apr; 235(1):95-100. PubMed ID: 8519285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
    Chin MH; Cioffi CL; Garay M; Neale RF; Shetty SS; DelGrande D; Mugrage B; Sills MA; Lipson KE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):74-83. PubMed ID: 8558459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
    Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics of [125I]TTA 386, ETA-selective antagonist.
    Pullen M; Brown G; Nambi P
    Neuropeptides; 1997 Aug; 31(4):345-9. PubMed ID: 9308022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between guanine nucleotide effect and reversible binding property of endothelin analogs.
    Nambi P; Pullen M; Aiyar N
    Neuropeptides; 1996 Feb; 30(1):109-14. PubMed ID: 8868308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.